HK1152892A1 - 用於治療急性瘧疾的二噻唑鎓鹽或者其前體和青蒿素或者其衍生物的組合 - Google Patents
用於治療急性瘧疾的二噻唑鎓鹽或者其前體和青蒿素或者其衍生物的組合Info
- Publication number
- HK1152892A1 HK1152892A1 HK11107109.0A HK11107109A HK1152892A1 HK 1152892 A1 HK1152892 A1 HK 1152892A1 HK 11107109 A HK11107109 A HK 11107109A HK 1152892 A1 HK1152892 A1 HK 1152892A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- artemisinin
- precursor
- bis
- derivative
- combination
- Prior art date
Links
- 230000001154 acute effect Effects 0.000 title 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 title 1
- 229960004191 artemisinin Drugs 0.000 title 1
- 229930101531 artemisinin Natural products 0.000 title 1
- 201000004792 malaria Diseases 0.000 title 1
- 239000002243 precursor Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0800618A FR2926993B1 (fr) | 2008-02-06 | 2008-02-06 | Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme |
| PCT/FR2009/000129 WO2009115666A2 (fr) | 2008-02-06 | 2009-02-05 | Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artémisinine ou l'un de ses derives pour le traitement du paludisme severe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1152892A1 true HK1152892A1 (zh) | 2012-03-16 |
Family
ID=39705083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK11107109.0A HK1152892A1 (zh) | 2008-02-06 | 2011-07-11 | 用於治療急性瘧疾的二噻唑鎓鹽或者其前體和青蒿素或者其衍生物的組合 |
Country Status (40)
| Country | Link |
|---|---|
| US (1) | US8304440B2 (zh) |
| EP (1) | EP2252286B1 (zh) |
| JP (1) | JP5469095B2 (zh) |
| KR (1) | KR20100137442A (zh) |
| CN (1) | CN101980706B (zh) |
| AP (1) | AP2613A (zh) |
| AR (1) | AR070581A1 (zh) |
| AT (1) | ATE521347T1 (zh) |
| AU (1) | AU2009227092B2 (zh) |
| BR (1) | BRPI0907484A2 (zh) |
| CA (1) | CA2714184A1 (zh) |
| CL (1) | CL2009000264A1 (zh) |
| CO (1) | CO6300843A2 (zh) |
| CR (1) | CR11613A (zh) |
| CY (1) | CY1112113T1 (zh) |
| DK (1) | DK2252286T3 (zh) |
| EA (1) | EA022711B1 (zh) |
| EC (1) | ECSP10010381A (zh) |
| ES (1) | ES2372148T3 (zh) |
| FR (1) | FR2926993B1 (zh) |
| HK (1) | HK1152892A1 (zh) |
| HR (1) | HRP20110858T8 (zh) |
| IL (1) | IL207442A0 (zh) |
| JO (1) | JO2820B1 (zh) |
| MA (1) | MA32128B1 (zh) |
| MX (1) | MX2010008653A (zh) |
| MY (1) | MY150776A (zh) |
| NI (1) | NI201000135A (zh) |
| NZ (1) | NZ587232A (zh) |
| PA (1) | PA8815101A1 (zh) |
| PE (1) | PE20091410A1 (zh) |
| PL (1) | PL2252286T3 (zh) |
| PT (1) | PT2252286E (zh) |
| RS (1) | RS52046B (zh) |
| SI (1) | SI2252286T1 (zh) |
| TW (1) | TWI402071B (zh) |
| UA (1) | UA99510C2 (zh) |
| UY (1) | UY31640A1 (zh) |
| WO (1) | WO2009115666A2 (zh) |
| ZA (1) | ZA201005611B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2951945B1 (fr) * | 2009-11-05 | 2013-08-09 | Sanofi Aventis | Composition pharmaceutique |
| CN105705177B (zh) | 2013-11-08 | 2019-10-22 | 艾克塞拉医疗公司 | 使用吸附介质诊断感染性疾病的方法 |
| US10714230B2 (en) * | 2017-12-06 | 2020-07-14 | C3Nano Inc. | Thin and uniform silver nanowires, method of synthesis and transparent conductive films formed from the nanowires |
| CN110604733A (zh) * | 2019-09-19 | 2019-12-24 | 同济大学 | 青蒿素类药物与其它药物联用在制备抗疟疾药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1058717A (zh) * | 1990-08-08 | 1992-02-19 | 中国人民解放军军事医学科学院微生物流行病研究所 | 抗疟新药—复方蒿甲醚及其制备方法 |
| FR2796642B1 (fr) * | 1999-07-21 | 2001-10-19 | Centre Nat Rech Scient | Precurseurs de sels de bis-ammonium quaternaire et leurs applications comme prodrogues ayant une activite anti-parasitaire |
| JP2003050535A (ja) * | 2001-08-07 | 2003-02-21 | T-Zone Corp | ネットワーク教育システム、ネットワーク教育方法、および、プログラム |
| FR2884715B1 (fr) * | 2005-04-20 | 2007-06-15 | Sanofi Aventis Sa | Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme |
-
2008
- 2008-02-06 FR FR0800618A patent/FR2926993B1/fr not_active Expired - Fee Related
-
2009
- 2009-02-01 JO JO200952A patent/JO2820B1/en active
- 2009-02-04 PE PE2009000161A patent/PE20091410A1/es not_active Application Discontinuation
- 2009-02-05 AT AT09721879T patent/ATE521347T1/de active
- 2009-02-05 NZ NZ587232A patent/NZ587232A/en not_active IP Right Cessation
- 2009-02-05 CA CA2714184A patent/CA2714184A1/fr not_active Abandoned
- 2009-02-05 EP EP09721879A patent/EP2252286B1/fr active Active
- 2009-02-05 EA EA201070923A patent/EA022711B1/ru not_active IP Right Cessation
- 2009-02-05 PA PA20098815101A patent/PA8815101A1/es unknown
- 2009-02-05 MY MYPI20103671 patent/MY150776A/en unknown
- 2009-02-05 PL PL09721879T patent/PL2252286T3/pl unknown
- 2009-02-05 SI SI200930113T patent/SI2252286T1/sl unknown
- 2009-02-05 MX MX2010008653A patent/MX2010008653A/es active IP Right Grant
- 2009-02-05 ES ES09721879T patent/ES2372148T3/es active Active
- 2009-02-05 RS RS20110508A patent/RS52046B/en unknown
- 2009-02-05 AU AU2009227092A patent/AU2009227092B2/en not_active Ceased
- 2009-02-05 WO PCT/FR2009/000129 patent/WO2009115666A2/fr active Application Filing
- 2009-02-05 KR KR1020107019691A patent/KR20100137442A/ko active IP Right Grant
- 2009-02-05 CL CL2009000264A patent/CL2009000264A1/es unknown
- 2009-02-05 BR BRPI0907484A patent/BRPI0907484A2/pt not_active IP Right Cessation
- 2009-02-05 CN CN2009801109704A patent/CN101980706B/zh not_active Expired - Fee Related
- 2009-02-05 PT PT09721879T patent/PT2252286E/pt unknown
- 2009-02-05 JP JP2010545524A patent/JP5469095B2/ja not_active Expired - Fee Related
- 2009-02-05 UA UAA201010670A patent/UA99510C2/ru unknown
- 2009-02-05 AP AP2010005353A patent/AP2613A/xx active
- 2009-02-05 DK DK09721879.6T patent/DK2252286T3/da active
- 2009-02-06 TW TW098103960A patent/TWI402071B/zh not_active IP Right Cessation
- 2009-02-06 UY UY031640A patent/UY31640A1/es not_active Application Discontinuation
- 2009-02-06 AR ARP090100409A patent/AR070581A1/es unknown
-
2010
- 2010-07-29 CR CR11613A patent/CR11613A/es not_active Application Discontinuation
- 2010-08-03 NI NI201000135A patent/NI201000135A/es unknown
- 2010-08-05 ZA ZA2010/05611A patent/ZA201005611B/en unknown
- 2010-08-05 EC EC2010010381A patent/ECSP10010381A/es unknown
- 2010-08-05 IL IL207442A patent/IL207442A0/en not_active IP Right Cessation
- 2010-08-06 US US12/851,747 patent/US8304440B2/en not_active Expired - Fee Related
- 2010-08-06 CO CO10096216A patent/CO6300843A2/es not_active Application Discontinuation
- 2010-09-01 MA MA33132A patent/MA32128B1/fr unknown
-
2011
- 2011-07-11 HK HK11107109.0A patent/HK1152892A1/zh not_active IP Right Cessation
- 2011-11-18 HR HR20110858T patent/HRP20110858T8/xx unknown
- 2011-11-24 CY CY20111101156T patent/CY1112113T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS000504I2 (hu) | Relebaktám, adott esetben monohidrát formájában, és imipenem kombinációja | |
| HK1243713A1 (zh) | 一種化合物的固體形式及其使用方法 | |
| HK1220705A1 (zh) | 急性淋巴細胞白血病的治療方法 | |
| EP2375903A4 (en) | METHOD FOR TREATING SILENTNESS | |
| EP2174912A4 (en) | PROCESS FOR MACHINING A COPPER ARSEN COMPOUND | |
| EP2059480A4 (en) | METHODS OF FORMING NANOPARTICLES | |
| GB0804213D0 (en) | A method of printing or preventing pain | |
| GB0817926D0 (en) | Articles of clothiing | |
| HK1145634A1 (en) | Treatment of atherosclerosis | |
| HK1152892A1 (zh) | 用於治療急性瘧疾的二噻唑鎓鹽或者其前體和青蒿素或者其衍生物的組合 | |
| EP2300496A4 (en) | ATHEROSCLEROSIS TREATMENT METHODS | |
| EP2181328A4 (en) | METHODS OF USING RET NANOCAPTERS | |
| GB0810063D0 (en) | Medicaments and methods for inhibition of scarring | |
| HK1175072A1 (zh) | -胺基吲哚化合物及治療瘧疾的方法 | |
| ZA201004357B (en) | Prodrugs of artemisinin | |
| EP2306838A4 (en) | METHOD FOR THE TREATMENT OF ATHEROSCLEROSIS | |
| GB2460445B (en) | Treatment of ringworm | |
| HK1133851A1 (en) | Method of coating | |
| PL1935603T3 (pl) | Sposób tworzenia pokrycia drzwi | |
| GB0802601D0 (en) | A method of forming article | |
| EP2331116A4 (en) | ANTI-INFECTIOUS COMPOUNDS AND USES THEREOF | |
| GB0821710D0 (en) | Derivatives of dihydroindolone | |
| GB0814856D0 (en) | A method of treating wood | |
| PL117542U1 (pl) | Zawieszka do biżuterii osobistej | |
| GB0625885D0 (en) | Methods of forming a door skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180205 |